Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
48 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Nuvo Research Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Nuvo Research Inc. - Product Pipeline Review - 2014', provides an overview of the Nuvo Research Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Nuvo Research Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Nuvo Research Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Nuvo Research Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Nuvo Research Inc.'s pipeline products Reasons to buy - Evaluate Nuvo Research Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Nuvo Research Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Nuvo Research Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Nuvo Research Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nuvo Research Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Nuvo Research Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Nuvo Research Inc. Snapshot 6 Nuvo Research Inc. Overview 6 Key Information 6 Key Facts 6 Nuvo Research Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Nuvo Research Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Combination Treatment Modalities 12 Nuvo Research Inc. - Pipeline Products Glance 13 Nuvo Research Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Nuvo Research Inc. - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Nuvo Research Inc. - Unknown Stage Pipeline Products 18 Unknown Products/Combination Treatment Modalities 18 Nuvo Research Inc. - Drug Profiles 19 (lidocaine + tetracaine) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Flexicaine 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 ropivacaine 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 triamcinolone acetonide 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 WF-10 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 alprazolam 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 lidocaine 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 ibuprofen 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Oxo-Foam 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 risperidone 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecules for Immunology 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 terbinafine 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 testosterone undecanoate 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 WF-10 liposomal 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Drug 1 for Dermatological Disorders 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Drug 2 for Dermatological Disorders 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Nuvo Research Inc. - Pipeline Analysis 37 Nuvo Research Inc. - Pipeline Products by Target 37 Nuvo Research Inc. - Pipeline Products by Route of Administration 39 Nuvo Research Inc. - Pipeline Products by Molecule Type 40 Nuvo Research Inc. - Pipeline Products by Mechanism of Action 41 Nuvo Research Inc. - Recent Pipeline Updates 42 Nuvo Research Inc. - Dormant Projects 44 Nuvo Research Inc. - Locations And Subsidiaries 45 Head Office 45 Other Locations & Subsidiaries 45 Appendix 47 Methodology 47 Coverage 47 Secondary Research 47 Primary Research 47 Expert Panel Validation 47 Contact Us 48 Disclaimer 48
List of Tables Nuvo Research Inc., Key Information 6 Nuvo Research Inc., Key Facts 6 Nuvo Research Inc. - Pipeline by Indication, 2014 9 Nuvo Research Inc. - Pipeline by Stage of Development, 2014 10 Nuvo Research Inc. - Monotherapy Products in Pipeline, 2014 11 Nuvo Research Inc. - Combination Treatment Modalities in Pipeline, 2014 12 Nuvo Research Inc. - Phase II, 2014 13 Nuvo Research Inc. - Phase I, 2014 14 Nuvo Research Inc. - IND/CTA Filed, 2014 15 Nuvo Research Inc. - Preclinical, 2014 16 Nuvo Research Inc. - Discovery, 2014 17 Nuvo Research Inc. - Unknown, 2014 18 Nuvo Research Inc. - Pipeline by Target, 2014 38 Nuvo Research Inc. - Pipeline by Route of Administration, 2014 39 Nuvo Research Inc. - Pipeline by Molecule Type, 2014 40 Nuvo Research Inc. - Pipeline Products by Mechanism of Action, 2014 41 Nuvo Research Inc. - Recent Pipeline Updates, 2014 42 Nuvo Research Inc. - Dormant Developmental Projects,2014 44 Nuvo Research Inc., Subsidiaries 45
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.